Herein, we report a case of a GLI1-altered mesenchymal tumor in a 36-year-old male with novel immunohistochemical staining for SSTR2A. As our knowledge of this recently described neoplasm continues to develop, it is important to further the understanding of its pathogenesis and different diagnostic tools to arrive at the correct diagnosis. This evidence concerns the gene GLI1 and neoplasm.